NCT02369575

Identification of Novel Markers of Human Lung Disease

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Ohio State University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate new therapies for advanced lung disease.

Detailed description

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.

Conditions

• Lung Diseases, Interstitial

Interventions

Type	Name	Description
OTHER	novel biomarkers of lung disease	we will be identifying molecular, genetic, and cellular markers of lung disease

Timeline

• Start date: 2015-02-01
• Primary completion: 2025-07-01
• Completion: 2025-07-01
• First posted: 2015-02-24
• Last updated: 2025-07-29

Locations

1 site across 1 country: United States